Explained: how to plot the prediction quality metrics with AlphaFold2
In a previous blog post, we discussed the importance of AlphaFold2 (as well as other, deep-learning...
BioStrand Omics Analysis Blog:
NLP
IPA MedTech Entrepreneurship Story at TU Delft
My name is Christophe Van Neste, Ph. D. and I am a bioinformatician and data scientist at IPA,...
A brief retrospective on our second blogiversary
It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...
AI in Biopharma: Challenges and Opportunities
There are an estimated novemdecillion, or 1060, molecules in the known universe with potential...
Closing the Gap of Text and the Biosphere with LENSai™ NLP Link
Bridging the gap between raw sequence data, secondary research, experimental data, and the...
Explained: A brief look into AlphaFold 2
The year 2021 has been a wild ride for structural biologists, with the advent of AlphaFold2,...
AI, NLP and the ROI of drug development
The out-of-pocket R&D costs of developing a single drug, whether successfully launched or not, are...
Accelerating pharma R&D and innovation through technology partnerships
Biopharmas are increasingly turning to alliances & partnerships to drive external innovation....
Computational Antibody Design: The Future Of Antibody Discovery
In 2021, the FDA approved the 100th monoclonal antibody product, marking a significant milestone...
Improving Drug Safety with Adverse Event Detection Using NLP
It is estimated that Adverse Events (AEs) are likely one of the 10 leading causes of death and...
A Hybrid Approach to NLP in Drug Discovery
Artificial Intelligence-powered technologies like NLP are becoming critical to the pharmaceutical...